Review

Current analysis of urinary biomarkers for prostate cancer

• Faruk Yencilek
• Hakan Koyuncu

What is the current status of bladder tumor markers?

• İbrahim Dönmez
• N. Aydın Mungan

Markers in upper urinary tract tumors

• Çağ Çal

Bladder cancer and genetics

• Ata Özen
• Cavit Can

Screening for Bladder Cancer: Reliability and Limitations

• Kamil Fehmi Narter
• Cahit Şahin

Is it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?

• Polat Türker
• Sinan Ekici

What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer?

• Hayrettin Şahin
• Mehmet Çetinkaya
• Hasan Deliktaş

NON-PSA biomarkers for prostate cancer

• Yarkın Kamil Yakupoğlu
• Yakup Bostancı
• Ender Özden

Evaluation of the Current Situation Tissue and Serum Biomarkers in Prostate Cancer

• Enis Kervancıoğlu
• Murat Koşan

Does Urinary Cytology Find the Value in the Detection and Follow-up of Urinary Bladder Cancer?

• Kutsal Yörükoğlu

Active Surveillance-Factors Affecting the Treatment Decision: 3M: “Marker”, “Mapping”, “MRI”

• Ender Özden
• Mehmet Necmettin Mercimek

Diagnostic and Prognostic Molecular Features of Urothelial Bladder Cancer and New Treatment Approaches

• Zafer Küçükodacı
• Kutsal Yörükoğlu

Original Article

Preoperative De Ritis Ratio for the Evaluation of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

• Ramazan İnan
• Alper Bitkin
• Mustafa Aydın
• Emrah Küçük
• Mustafa Kemal Atilla
• Lokman İrkilata

Prognostic Values of Inflammatory Markers in Patients with High-grade Lamina Propria-invasive Bladder Cancer

• İsmail Önder Yılmaz
• Mutlu Değer
• Nebil Akdoğan
• İbrahim Atilla Arıdoğan
• Yıldırım Bayazıt
• Volkan İzol

Vascular Endothelial Growth Factor and Thrombospondin-1 mRNA Expression in Bladder Tumors: Correlation with Histopathology and Prognosis

• Bora Özveren
• Levent Türkeri

Fiducial Marker Practice in Prostate Radiotherapy in Turkey

• Menekşe Turna
• Halil Akboru

Role of Tissue Markers on Predicting the Prognosis of Intermediate and High-risk Non-muscle Invasive Bladder Cancer

• Abulfaz Abbaslı
• Sinharib Çitgez
• Çetin Demirdağ
• Ahmet Gürbüz
• Ahmet Erözenci

Original Articles

Evaluation of Role of Inflammatory Markers for the Prediction of Recurrence on Pathologic T1a Clear Cell Renal Cell Cancer Patients

• Mehmet İlker Gökçe
• Nurullah Hamidi
• Barış Esen
• Semih Tangal
• Evren Süer
• Sümer Baltacı

Review

The Diagnostic and Prognostic Significance of MicroRNA-21 in Non-muscle Invasive Bladder Tumors

• Önder Çınar
• Necmettin Aydın Mungan

Evaluation of Current Status of Urine and Serum Biomarkers in the Diagnosis and Follow-up of Bladder Cancer: Review

• Mehmet Yıldızhan
• Hakan Gemalmaz

Bph

Prostatic inflammation as a target of etiopathogenesis and treatment

• Murat Koşan
• Umut Gönülalan